We are very happy to announce the release of our latest study in the European Journal of Pharmaceutics and Biopharmaceutics. This publication highlights the outstanding characterization results of our innovative drug candidate developed by VRT for the treatment of exocrine pancreatic insufficiency.
Congratulations to Cloé Fabre, Jessica Tran and the entire Eneapharm team for this remarkable achievement, which marks a significant step forward in the development of more effective therapeutic solutions for patients.
This work was carried out by Alexis Bages via a cifre contract funded by Eneapharm in connection with INSA.
